Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 5, 2026 01:21 UTC |
Reed JoshuaSVP, Chief Financial Officer
|
GrantRestricted Stock Unit Award · Derivative | 30,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001520262-26-000063 · form4.xml · derivative · entry 2 Reed Joshua · CIK 0001746541 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,854 Underlying: Ordinary Shares · 30,854 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:21 UTC |
Reed JoshuaSVP, Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 66,430 | $0.00 Strike: $30.25 | $0.00 |
DisclosureSEC source: 0001520262-26-000063 · form4.xml · derivative · entry 1 Reed Joshua · CIK 0001746541 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,430 Underlying: Ordinary Shares · 66,430 shares Expires 2036-03-02 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:19 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
GrantRestricted Stock Unit Award · Derivative | 14,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001520262-26-000061 · form4.xml · derivative · entry 3 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,176 Underlying: Ordinary Shares · 14,176 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:19 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,033 | $0.00 Strike: $30.25 | $0.00 |
DisclosureSEC source: 0001520262-26-000061 · form4.xml · derivative · entry 2 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,033 Underlying: Ordinary Shares · 15,033 shares Expires 2036-03-02 F2 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:19 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
SaleOrdinary Shares | 6,890 | $29.29 | $201,808.10 |
DisclosureSEC source: 0001520262-26-000061 · form4.xml · nonDerivative · entry 1 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,717 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/7/2025. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:17 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantRestricted Stock Unit Award · Derivative | 44,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001520262-26-000059 · form4.xml · derivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,078 Underlying: Ordinary Shares · 44,078 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:17 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 94,900 | $0.00 Strike: $30.25 | $0.00 |
DisclosureSEC source: 0001520262-26-000059 · form4.xml · derivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,900 Underlying: Ordinary Shares · 94,900 shares Expires 2036-03-02 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:16 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantRestricted Stock Unit Award · Derivative | 38,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001520262-26-000058 · form4.xml · derivative · entry 5 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,568 Underlying: Ordinary Shares · 38,568 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F7 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. F7 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:16 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 83,037 | $0.00 Strike: $30.25 | $0.00 |
DisclosureSEC source: 0001520262-26-000058 · form4.xml · derivative · entry 4 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,037 Underlying: Ordinary Shares · 83,037 shares Expires 2036-03-02 F5 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:16 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $19.34 | $0.00 |
DisclosureSEC source: 0001520262-26-000058 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,356 Underlying: Ordinary Shares · 5,000 shares Expires 2031-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:16 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
SaleOrdinary Shares | 9,000 | $29.72 | $267,485.40 |
DisclosureSEC source: 0001520262-26-000058 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,389 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.29 to $30.13. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:16 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 5,000 | $19.34 | $96,700.00 |
DisclosureSEC source: 0001520262-26-000058 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 98,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:15 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 36,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001520262-26-000057 · form4.xml · derivative · entry 4 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,364 Underlying: Ordinary Shares · 36,364 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:15 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 78,292 | $0.00 Strike: $30.25 | $0.00 |
DisclosureSEC source: 0001520262-26-000057 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,292 Underlying: Ordinary Shares · 78,292 shares Expires 2036-03-02 F2 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 3/2/2027. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 01:15 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
SaleOrdinary Shares | 2,034 | $29.29 | $59,575.86 |
DisclosureSEC source: 0001520262-26-000057 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 237,660 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/19/2025. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:40 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 5,410 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000048 · form4.xml · derivative · entry 3 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,819 Underlying: Ordinary Shares · 5,410 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:40 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 2,403 | $30.73 | $73,844.19 |
DisclosureSEC source: 0001520262-26-000048 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,769 Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:40 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionOrdinary Shares | 5,410 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000048 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:40 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,747 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000049 · form4.xml · derivative · entry 3 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,493 Underlying: Ordinary Shares · 2,747 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:40 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Tax withholdingOrdinary Shares | 808 | $30.73 | $24,829.84 |
DisclosureSEC source: 0001520262-26-000049 · form4.xml · nonDerivative · entry 2 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,607 Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:40 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionOrdinary Shares | 2,747 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000049 · form4.xml · nonDerivative · entry 1 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:39 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000047 · form4.xml · derivative · entry 3 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,645 Underlying: Ordinary Shares · 8,322 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:39 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 3,695 | $30.73 | $113,547.35 |
DisclosureSEC source: 0001520262-26-000047 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,308 Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:39 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 8,322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000047 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:37 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000045 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,732 Underlying: Ordinary Shares · 6,866 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:37 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 3,049 | $30.73 | $93,695.77 |
DisclosureSEC source: 0001520262-26-000045 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,694 Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:37 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 6,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000045 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:38 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000046 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,732 Underlying: Ordinary Shares · 6,866 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/26/2025. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:38 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 3,049 | $30.73 | $93,695.77 |
DisclosureSEC source: 0001520262-26-000046 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,389 Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:38 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 6,866 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000046 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,438 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:48 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000037 · form4.xml · derivative · entry 3 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,408 Underlying: Ordinary Shares · 6,407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:48 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 2,845 | $32.19 | $91,580.55 |
DisclosureSEC source: 0001520262-26-000037 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,762 Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:48 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionOrdinary Shares | 6,407 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000037 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:49 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000039 · form4.xml · derivative · entry 3 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,284 Underlying: Ordinary Shares · 2,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:49 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Tax withholdingOrdinary Shares | 672 | $32.19 | $21,631.68 |
DisclosureSEC source: 0001520262-26-000039 · form4.xml · nonDerivative · entry 2 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,668 Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:49 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionOrdinary Shares | 2,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000039 · form4.xml · nonDerivative · entry 1 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:47 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000035 · form4.xml · derivative · entry 3 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,738 Underlying: Ordinary Shares · 8,738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:47 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 3,880 | $32.19 | $124,897.20 |
DisclosureSEC source: 0001520262-26-000035 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,681 Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:47 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 8,738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000035 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,561 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:46 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000033 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,690 Underlying: Ordinary Shares · 7,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:46 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 3,414 | $32.19 | $109,896.66 |
DisclosureSEC source: 0001520262-26-000033 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,572 Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:46 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000033 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:44 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000031 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,690 Underlying: Ordinary Shares · 7,689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:44 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 3,414 | $32.19 | $109,896.66 |
DisclosureSEC source: 0001520262-26-000031 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,877 Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:44 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000031 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:24 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000028 · form4.xml · derivative · entry 6 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,137 Underlying: Ordinary Shares · 6,045 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:24 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 2,277 | $32.00 | $72,864.00 |
DisclosureSEC source: 0001520262-26-000028 · form4.xml · nonDerivative · entry 4 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,200 Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:24 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionOrdinary Shares | 6,045 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000028 · form4.xml · nonDerivative · entry 3 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:25 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,991 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001520262-26-000029 · form4.xml · derivative · entry 6 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,974 Underlying: Ordinary Shares · 2,991 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 21:25 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Tax withholdingOrdinary Shares | 979 | $32.00 | $31,328.00 |
DisclosureSEC source: 0001520262-26-000029 · form4.xml · nonDerivative · entry 4 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,057 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.